The term KIAA1822L Activators suggests a class of chemical compounds postulated to interact with a protein encoded by a gene that might be designated as KIAA1822L. The KIAA nomenclature originates from a series of genes identified by the Kazusa DNA Research Institute, where many of these genes were initially cataloged without detailed functional information. The protein KIAA1822L would, therefore, require initial investigative research to determine its cellular role, expression patterns, and biochemical properties. If KIAA1822L activators existed, they would be molecules designed to enhance the activity of this protein, which would involve increasing its expression, activity, stability, or modulating its interactions with other cellular components. The design and discovery process of such activators would likely be initiated by high-throughput chemical screening, aiming to identify compounds that can positively modulate the protein's function. Subsequent validation steps would include verifying the specificity of these activators to ensure that the observed effects are due to direct interaction with the KIAA1822L protein.
Developing a deeper understanding of the interaction between KIAA1822L activators and their target protein would involve a series of advanced analytical techniques. Researchers might employ methods such as affinity chromatography to quantify the binding affinity of the activators, or use mass spectrometry to elucidate the molecular weight and structural features of the protein-activator complexes. Additionally, computational tools like molecular dynamics simulations could predict how the activators affect the protein's structure and function. Nuclear magnetic resonance (NMR) spectroscopy could provide insights into the conformational changes within the protein upon activator binding. Through these methods, scientists would seek to map the activator binding sites, understand the mechanism of activation, and characterize the molecular interactions at play. This detailed molecular characterization would be essential for researchers to fully grasp the biochemical implications of activating the KIAA1822L protein, even though, as of now, such a protein and its corresponding activators are purely speculative and not grounded in the current scientific literature.
VEDI ANCHE...
Items 1 to 10 of 12 total
Schermo:
| Nome del prodotto | CAS # | Codice del prodotto | Quantità | Prezzo | CITAZIONI | Valutazione |
|---|---|---|---|---|---|---|
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $92.00 $204.00 | 19 | |
Un inibitore della via di segnalazione Hh che può aumentare la regolazione di HHIPL2 come risposta compensatoria. | ||||||
Purmorphamine | 483367-10-8 | sc-202785 sc-202785A | 1 mg 5 mg | $56.00 $180.00 | 18 | |
Attiva la via Hh e potrebbe potenzialmente aumentare l'espressione di geni correlati come HHIPL2. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Aumenta i livelli di cAMP, che può influenzare l'espressione dei geni della via Hh, compreso HHIPL2. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $70.00 $160.00 $290.00 | 2 | |
Può modulare varie vie di sviluppo e differenziazione, influenzando potenzialmente l'espressione di HHIPL2. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Regolatore dell'espressione genica durante lo sviluppo, può influenzare l'espressione di HHIPL2. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Il litio può attivare la segnalazione Wnt e può influenzare indirettamente la via Hh e l'espressione di HHIPL2. | ||||||
Cholesterol | 57-88-5 | sc-202539C sc-202539E sc-202539A sc-202539B sc-202539D sc-202539 | 5 g 5 kg 100 g 250 g 1 kg 25 g | $26.00 $2754.00 $126.00 $206.00 $572.00 $86.00 | 11 | |
Il colesterolo è un precursore dei ligandi Hh e i suoi livelli possono influenzare la segnalazione della via Hh. | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $62.00 $260.00 | 21 | |
Antimicotico che inibisce la sintesi di steroli e può perturbare la segnalazione Hh, influenzando l'espressione di HHIPL2. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $28.00 $88.00 $332.00 | 12 | |
In quanto inibitori della sintesi del colesterolo, le statine possono modulare la via Hh e quindi l'espressione di HHIPL2. | ||||||
GANT61 | 500579-04-4 | sc-202630 sc-202630A sc-202630B | 1 mg 5 mg 10 mg | $63.00 $128.00 $200.00 | 6 | |
Un inibitore specifico del fattore di trascrizione GLI della segnalazione Hh, che può alterare l'espressione di HHIPL2. | ||||||